Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 1.12 M1.5 M — Research & development —— — Operating income -3.95 M-4.56 M — Non-Operating Income, Total -40.39 K-48.5 K — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses -64.42 K-67.84 K — Unusual income/expense 24.03 K19.34 K — Pretax income -3.99 M-4.6 M — Equity in earnings —— — Taxes 4 1504 365 — Non-controlling/minority interest -35.26 K-107.6 K — After tax other income/expense —— — Net income before discontinued operations -3.88 M-4.44 M — Discontinued operations —— — Net income -3.88 M-4.44 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -3.88 M-4.44 M — Basic earnings per share (Basic EPS) -1.3-1.19 — Diluted earnings per share (Diluted EPS) -1.3-1.19 — Average basic shares outstanding 2.9 M3.73 M — Diluted shares outstanding 2.9 M3.73 M — EBITDA -2.94 M-2.24 M — EBIT -4.01 M-4.62 M — Cost of revenue 162.73 K204.87 K — Other cost of goods sold —— — Depreciation & amortization (cash flow) 1.07 M2.38 M —